Dihydralazine (sulfate)

Dihydralazine sulfate is a vasodilator and an antihypertensive agent[1][2].

Product Specifications

CAS Number

[7327-87-9]

UNSPSC

12352005

Hazard Statement

H302, H312, H332

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Neuroscience-Neuromodulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/dihydralazine-sulfate.html

Purity

98.0

Solubility

DMSO : 4.17 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

N/N=C(C1=C/2C=CC=C1)\NNC2=N/N.O=S(O)(O)=O

Molecular Formula

C8H12N6O4S

Molecular Weight

288.28

Precautions

H302, H312, H332

References & Citations

[1]Bijvank SW, et al. Ketanserin versus dihydralazine for the treatment of severe hypertension in early-onset preeclampsia: a double blind randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:106-11.|[2]Barry DI, et al. Cerebral blood flow during dihydralazine-induced hypotension in hypertensive rats. Stroke. 1984 Jan-Feb;15 (1) :102-8.